Michael Scolaro

Michael Scolaro

Aug 28, 2017

Group 6 Copy 194
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Can people be screened for acute mountain sickness susceptibility?

    This project aims to investigate cerebral deoxygenation during exercise in hypoxia in order to highlight a potential...

    Making Inexpensive Insulin Using Microalgae

    This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae before...

    Backer Badge Funded